Rationale and design of a clinical trial to assess Lp(a) lowering with ionis-apo(a)-LRX in patients undergoing apheresis for elevated Lp(a) and recurrent cardiovascular events

Autor:	Moriarty, P.M., Thiessen, E.S., Witztum, J.L., Viney, N.J., Tsimikas, S.
Zdroj:	In Atherosclerosis September 2016 252:e123-e123
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect